James Seyffart recently indicated on X that there have been developments with Bitcoin ETF options.
He noted that while CBOE withdrew their application for spot Bitcoin ETF options, they promptly submitted a revised one.
Three smaller exchanges, BOX Exchange, MIAX Pearl, and Miami International Securities Exchange, also pulled their applications to list spot Bitcoin ETFs. Seyffart and Eric Balchunas, a senior ETF analyst at Bloomberg, both emphasized that the major exchanges—Nasdaq, NYSE, and CBOE—still have active applications, which are the ones that really matter.
Seyffart predicted that options could be added to spot Bitcoin ETFs in the U.S. by the fourth quarter of this year, possibly starting as early as the third quarter.
The final decision from the SEC is expected around September 21, with additional approvals needed from the OCC and CFTC. He also mentioned that numerous BTC and ETH-related ETFs, including leveraged products, already offer options.
On August 7, Nasdaq and BlackRock filed to add options to BlackRock’s spot Ethereum ETF, the iShares Ethereum Trust. The SEC has 21 days to comment, with a final deadline around April 9, 2025.
Nasdaq also highlighted other commodity ETFs with listed options, such as BlackRock’s iShares COMEX Gold Trust and iShares Silver Trust.
A new report from analytics firm Alphractal is shedding light on a potential recurring pattern in the Bitcoin market that could hint at incoming volatility followed by a period of price stability.
Japanese investment firm Metaplanet is rapidly scaling up its Bitcoin exposure, with the company disclosing a fresh purchase of 1,004 BTC in its latest filing.
Bitcoin, now valued around $2 trillion, has entered a new phase in its evolution — one that may see its total market capitalization rival gold’s $22 trillion dominance, according to several prominent investors.
Strategy, the business intelligence firm renowned for its relentless Bitcoin accumulation, has just made another massive investment — snapping up $765 million worth of BTC in its latest buy.